» Authors » Peter C Huijgens

Peter C Huijgens

Explore the profile of Peter C Huijgens including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 73
Citations 1526
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hermans S, van der Maas N, van Norden Y, Dinmohamed A, Berkx E, Huijgens P, et al.
JAMA Oncol . 2024 Aug; 10(10):1426-1436. PMID: 39207765
Importance: The use of real-world data (RWD) external control arms in prospective studies is increasing. The advantages, including the immediate availability of a control population, must be balanced with the...
2.
Boddaert M, Douma J, Dijxhoorn A, Heman R, van der Rijt C, Teunissen S, et al.
PLoS One . 2022 Mar; 17(3):e0265726. PMID: 35320315
In a predominantly biomedical healthcare model focused on cure, providing optimal, person-centred palliative care is challenging. The general public, patients, and healthcare professionals are often unaware of palliative care's benefits....
3.
Kruijthoff D, Bendien E, van der Kooi C, Glas G, Abma T, Huijgens P
Explore (NY) . 2021 May; 18(4):475-482. PMID: 34052122
Aim: to enhance the understanding of documented mismatches between 'subjective' experiences and 'objective' data in three cases of self-reported instantaneous healing of hearing impairment upon prayer. Method: description of three...
4.
Blommestein H, Franken M, van Beurden-Tan C, Blijlevens N, Huijgens P, Sonneveld P, et al.
JAMA Netw Open . 2021 Mar; 4(3):e213497. PMID: 33779744
Importance: Although the number of treatments for elderly patients with non-transplant-eligible (NTE) multiple myeloma (MM) has increased substantially, evidence is lacking on the clinical effectiveness and cost-effectiveness of novel treatment...
5.
Uyl-de Groot C, Schuurman M, Huijgens P, Praagman J
TSG . 2020 Dec; 99(1):1-8. PMID: 33324131
The COVID-19 crisis and the intelligent lockdown have led to a situation in which the Dutch health care system was locked for months for non-COVID-19 patients. Patients did not dare...
6.
Issa D, Dinmohamed A, Wondergem M, Blommestein H, Huijgens P, Lugtenburg P, et al.
Leuk Lymphoma . 2020 Nov; 62(3):549-559. PMID: 33213245
Randomized controlled trials have studied different dose-intensity and dose-interval regimens of R-CHOP for patients with diffuse large B-cell lymphoma (DLBCL). This study was undertaken to confirm these results in a...
7.
van Maaren M, Kneepkens R, Verbaan J, Huijgens P, Lemmens V, Verhoeven R, et al.
PLoS One . 2019 Jan; 14(1):e0210887. PMID: 30677053
Objective: Many cancer survivors are facing difficulties in getting a life insurance; raised premiums and declinatures are common. We generated a prediction model estimating the conditional extra mortality risk of...
8.
Husson O, Huijgens P, van der Graaf W
Blood . 2018 Jun; 132(4):385-392. PMID: 29895664
Adolescents and young adults (AYAs) occupy a unique place within the hematologic malignancy community due to the challenges they face related to their disease biology and physical, psychosocial, and economic...
9.
Dinmohamed A, Visser O, Posthuma E, Huijgens P, Sonneveld P, van de Loosdrecht A, et al.
Cancer Epidemiol . 2017 Sep; 50(Pt A):137-140. PMID: 28910695
Background: Morphologic and cytogenetic assessments are required to characterize diagnostic and prognostic features of myelodysplastic syndromes (MDS). We assessed whether these assessments were performed among newly diagnosed MDS patients in...
10.
Holla J, van de Poll-Franse L, Huijgens P, Mols F, Dekker J
Support Care Cancer . 2016 Feb; 24(7):2883-92. PMID: 26842528
Purpose: In an equitable healthcare system, healthcare utilization should be predominantly explained by patient-perceived need and clinical need factors. This study aims to analyze whether predisposing, enabling, and need factors...